Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 17
1976 38
1977 29
1978 42
1979 38
1980 24
1981 29
1982 39
1983 27
1984 33
1985 16
1986 18
1987 13
1988 17
1989 8
1990 8
1991 9
1992 8
1993 1
1994 7
1995 4
1996 2
1997 3
1998 2
1999 1
2000 5
2001 1
2002 2
2004 3
2005 1
2006 2
2007 3
2008 1
2009 3
2010 2
2011 5
2012 1
2013 2
2014 1
2015 4
2016 2
2017 1
2019 2
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

476 results

Results by year

Filters applied: . Clear all
Page 1
Nephrotoxicity of semustine.
Weiss RB, Posada JG Jr, Kramer RA, Boyd MR. Weiss RB, et al. Cancer Treat Rep. 1983 Dec;67(12):1105-12. Cancer Treat Rep. 1983. PMID: 6360348 Review.
Treatment of brain tumors.
Walker MD. Walker MD. Med Clin North Am. 1977 Sep;61(5):1045-51. doi: 10.1016/s0025-7125(16)31280-9. Med Clin North Am. 1977. PMID: 197350 Review. No abstract available.
Methyl-CCNU inclinical cancer therapy.
Wasserman TH, Slavik M, Carter SK. Wasserman TH, et al. Cancer Treat Rev. 1974 Dec;1(4):251-69. doi: 10.1016/s0305-7372(74)80018-6. Cancer Treat Rev. 1974. PMID: 4377543 Review. No abstract available.
CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients.
Wang T, Liu P, Xu L, Gao L, Ni X, Tang G, Chen L, Chen J, Wang L, Wang Y, Fu W, Yue W, Liu N, Li R, Lu G, Luo Y, Yang J. Wang T, et al. Ann Hematol. 2024 Feb;103(2):575-582. doi: 10.1007/s00277-023-05513-x. Epub 2023 Nov 6. Ann Hematol. 2024. PMID: 37932468
476 results